34
Views
68
CrossRef citations to date
0
Altmetric
Original Article

Clinical usefulness of serum tartrate-resistant acid phosphatase activity determination to evaluate bone turnover

, , , , , & show all
Pages 517-524 | Received 12 Sep 1990, Accepted 17 Apr 1991, Published online: 08 Jul 2009

References

  • Eriksen E F, Steiniche T, Mosekilde L, Melsen F. Histomorphometric analysis of bone in metabolic bone disease. Endocrinol Metabol Clinics North America. 1989; 18: 919–54
  • Charles P, Eriksen E F, Mosekilde L, Melsen F, Jensen FT. Bone turnover and balance evaluated by a combined calcium balance and 47calcium kinetic study and dynamic histomorphometry. Metabolism 1987; 36: 1118–24
  • Hildstrup L, McNair P, Jensen G F, Mogensen N B, Transbøl I. Measurements of whole body retention of diphosphonate and other indices of bone metabolism in 125 normals: dependency of age, sex and glomerular filtration. Scand J Clin Lab Invest 1984; 44: 673–8
  • Yam LT. Clinical significance of the human acid phosphatases. Am J Med 1974; 56: 604–16
  • Lam W KW, Eastlund D T, Li C Y, Yam LT. Biochemical properties of tartrate-resistant acid phosphatase in serum of adults and children. Clin Chem 1978; 24: 1105–8
  • Minkin C. Bone acid phosphatase: tartrate-resistant acid phosphatase as a marker of osteoclast function. Calcif Tissue Int 1982; 34: 285–90
  • Miller SC. The rapid appearance of acid phosphatase activity at the developing ruffled border of parathyroid hormone-activated medullary bone osteoclasts. Calcif Tissue Int 1985; 37: 526–9
  • Stepan J J, Silinkova-Malkova E, Havranek T, Formenkova J, Zichova M, Lachmanova J, Strakova M, Broulik P, Pacovsky V. Relationship of plasma tartrate-resistant acid phosphatase to the bone isoenzyme of serum alkaline phosphatase in hyperparathyroidism. Clin Chim Acta 1983; 133: 189–200
  • Lam K W, Siemens M, Sun T, Li C Y, Lam LT. Enzyme immunoassay for tartrate-resistant acid phosphatase. Clin Chem 1982; 28: 467–70
  • Lam K W, Lai L, Lam LT. Tartrate-resistant (band 5) acid phosphatase activity measured by electrophoresis on acrylamide gel. Clin Chem 1980; 26: 420–2
  • Rettinger S D, Whyte MP. Normal circulating acid phosphatase activity in hypophosphatasia. J Inher Metab Dis 1985; 8: 161–2
  • Cooper JDH, Turnell DC, Price CP. The estimation of serum acid phosphatase using alpha-naphthyl phosphate as substrate: observations on the use of Fast Red TR salt in the assay. Clin Chim Acta 1982; 126: 297–306
  • Bais R, Edwards JB. An optimized continuous-monitoring procedure for semi-automated determination of serum acid phosphatase activity. Clin Chem 1976; 22: 2025–8
  • Lau K HW, Onishi T, Wergedal JE., Singer F R, Baylink DJ. Characterization and assay of tartrate-resistant acid phosphatase activity in serum: potential use to assess bone resorption. Clin Chem 1987; 33: 458–62
  • Minisola S, Scarnecchia L, Scarda A, Bigi F, Tabolli S, Valtorta C, Mazzuoli GF. Serum osteocalcin in primary hyperparathyroidism: short-term effect of surgery. Mineral Electrolyte Metab 1988; 14: 201–7
  • Minisola S, Pacitti M T, Romagnoli E, Scarnecchia L, Carnevale V, Scarpiello A, Mazzouli GF. Falsely normal values of intact parathyrin in serum of patients with mild primary hyperparathyroidism?. Clin Chem 1990; 36: 810–1
  • Mazzuoli G F, Passeri M, Gennari C, Minisola S, Antonelli R, Valtora C, Palummeri E, Cervellin G F, Gonnelli S, Francini G. Effects of salmon calcitonin in postmenopausal osteoporosis: a controlled double-blind clinical study. Calcif Tissue Int 1986; 38: 3–8
  • Mazzouli G F, Minisola S, Valtorta C, Antonelli R, Tabolli S, Bigi F. Changes in mineral content and biochemical bone markers at the menopause. Isr J Med Sci 1985; 21: 875–7
  • Mazzuoli G F, TabolliBigi S. F., Minisola S, Valtorta C, Scarda A, Scassellati G. Changes in bone remodelling and calcium-phosphorus metabolism following oophorectomy. Calcif Tissue Int 1986; 39: A56, Suppl.
  • Aaron JE. Histology and micro-anatomy of bone. Calcium, Phosphate and Magnesium Metabolism, BEC Nordin. Churchill Livingstone, London 1976; 298–356
  • Wronski T J, Cintron M, Dann LM. Temporal relationship between bone loss and increased bone turnover in ovariectomized rats. Calcif Tissue Int. 1988; 43: 179–83
  • Nordin B EC, Policy KJ. Metabolic consequences of the menopause. Calcif Tissue Int 1987; 41: S1–S59, Suppl. 1
  • Mazzuoli G Fď, Erasmo E, Minisola S, Tabolli S, Bigi F, Bianchi G. Pathogenetic aspects of involutional osteoporosis. Clin Rheumatol 1989; 8: 22–9, Suppl. 2
  • Nordin B EC. The definition and diagnosis of osteoporosis. Calcif Tissue Int 1987; 40: 57–8
  • Minisola S, Scarnecchia L, Carnevale V, Bigi F, Romagnoli E, Pacini M T, Rosso R, Mazzuoli GF. Clinical value of the measurement of bone remodelling markers in primary hyperparathyroidism. J Endocrinol Invest 1989; 12: 537–42
  • Mazzuoli G Fď, Erasmo E, Scarda A, Mancini D, Minisola S, MalagutiAliberti L, Valtora C. Calcitonin secretion and bone disease severity in hypercalcaemic hyperparathyroidism. Clin Endocrinol 1981; 15: 81–6
  • Wergedal J E, Baylink DJ. Characterization of cells isolated and cultured from human bone. Proc Soc Exp Biol Med 1984; 176: 27–31
  • Bianco P, Ballanti P, Bonucci E. Tartrate-resistant acid phosphatase activity in rat osteoblasts and osteocytes. Calcif Tissue Int 1988; 43: 167–71
  • Allen S H, Nuttleman P R, Ketcham C M, Roberts RM. Purification and characterization of human bone tartrate-resistant acid phosphatase. J Bone Min Res 1989; 4: 47–55

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.